Sign in
4

Changes in Ownership

IRONWOOD PHARMACEUTICALS INC Filed Acc 0001193125-26-006290

Principal Accounting Officer sold 35,416 shares at $4.60 ($162,914)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Silver Ronald Principal Accounting Officer 2026-01-05 Sale 10b5-1 −35,416 $4.60 $162,914 276,809 D: show line 1 in the form
Open-market sales · 35,416 sh · avg $4.60 · $162,914
Loading xslF345X05/ownership.xml…